The ALEX RS is a bilateral upper-limb exoskeleton designed for post-stroke rehabilitation, covering 92% of the human arm's natural range of motion and is CE certified as a Class IIa medical device.
Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.
WINT Design Lab envisions regenerative futures through devices and biotextiles that allow humans to connect with their bodies more and free themselves from fossil materials that harm them and the environment.
The body of the robotic fingers is built from polyglycerol sebacate, a synthetic elastomer made from glycerol and sebacic acid. Glycerol is a byproduct of biodiesel production while sebacic acid is derived from castor oil, and both of them are plant-based. Polyglycerol sebacate is safe since it is already used in medical implants because the body can absorb it without a toxic response.
I am running. Ahead lie endless mangrove swamps, behind the green-blue waters of the Caribbean. My mind is rising away from my lurching body, which is on a treadmill and attached to a beeping machine by wires and tubes. Nurses circle. The gradient increases, as does the speed. Dignity slips away as my body fights for breath. They're after my "VO2 max", the amount of oxygen my body can absorb during my maximum capacity for exercise.
An exoskeleton is a relatively new class of wearable device designed to enhance, support, or assist human movement, strength, posture, or even physical activity. The main piece goes around your waist like a belt, and from it, a pair of hinged, mechanized splints extend down over the hips to strap onto each thigh, where they provide some robotic assistance to normal movements like walking, running, or squatting.
Before treatment began, participants underwent neuroimaging. Instead of relying on a single modality, the researchers fused structural connectivity (how regions are physically wired) with functional connectivity (how regions co-activate at rest). The goal was not to throw every possible feature at a black box, but to learn a constrained pattern-what the authors call structure-function "covariation"-that carries the most predictive signal for outcome. In other words, the model tries to find the smallest set of connections that meaningfully forecasts symptom change.
More than 17,500 patients are living on the waiting list at any given time for a liver transplant. Unfortunately, there aren't enough of the available, donated organs to go around, leading to a critical and frequently deadly backlog. Roughly 10% of the patients on that waiting list die each year while waiting for the prospect of a new organ.
When you have an acute injury, your body is sending signals through the peripheral and central nervous systems and the immune system to say, hold on, I need to stop doing this so we can allow the tissue to heal, says Ericka Merriwether, a physical therapist and pain researcher at New York University. Rest, after all, is the first part of the familiar RICE therapy, which stands for rest, ice, compression and elevation.
Now, researchers have created an artificial-intelligence system that vastly simplifies and accelerates the process of chemical synthesis. The system, which is called MOSAIC and is described in a study published in Nature on 19 January, recommended conditions that researchers were able to use to generate 35 compounds with the potential to become products like pharmaceuticals, agrochemicals or cosmetics without needing to do any further trawling or tweaking.
'Stem cell-based' treatments and just the latest aesthetic treatment marketed to those seeking to maintain or obtain youthful skin, but what exactly is involved and what's the evidence that they work It's hard to keep track of the number of scientifically based beauty treatments on offer these days. Most are aimed at middle-aged females with disposable incomes, who are willing to splash large amounts of money on their skin to counter the effects of time.
A study led by Stanford Medicine researchers has found that an injection blocking a protein linked to aging can reverse the natural loss of knee cartilage in older mice. The same treatment also stopped arthritis from developing after knee injuries that resemble ACL tears, which are common among athletes and recreational exercisers. Researchers note that an oral version of the treatment is already being tested in clinical trials aimed at treating age-related muscle weakness.
Artificial intelligence has taken the medical device industry by storm - even adding a layer of complexity to the operating room that's resulting in patients being hurt, some health professionals claim. As Reuters reports, the TruDi Navigation System by device maker Acclarent was designed to treat chronic sinusitis, inflammation of the nasal sinuses, by inserting a tiny balloon to enlarge the sinus cavity openings.
When surgeons removed a 33-year-old woman's right lung as part of her cancer treatment in 1995, they expected a dramatic and permanent reduction in her breathing power. But that's not what happened. Instead, her remaining lung pulled off a trick that scientists had long thought impossible in humans: it grew new tissue, and lots of it. Over the next 15 years, her left lung compensated for the loss of its partner by nearly doubling in volume and growing millions of new air sacs, called alveoli.
Bracesys sidesteps all these limitations with an adjustable framework of segmented units, articulating connectors, and tension dials. The entire system weighs just 150 grams and folds flat into an envelope, yet provides rigid support comparable to traditional casts. More remarkably, clinicians can customize it to each patient's anatomy in real time, adjusting the fit as swelling decreases and healing progresses.
EMPAVELI is the first and only approved treatment for C3G and IC-MPGN across pediatric patients 12+, adults, and post-transplant recurrence. That's roughly 5,000 patients in the U.S., with EMPAVELI holding exclusive approval for about two-thirds. Add the European CHMP positive opinion in December 2025, and you have a rare disease franchise with global expansion potential and pricing power that typically commands gross margins north of 90%.
Anais Muczynski, 36, an orthoptist who lives with her husband Vincent Muczynski, 41, a researcher, received her primary breast cancer diagnosis in January 2023 after discovering a quail egg-sized lump in her left breast. At the time, the London-based couple were "optimistic", as it was stage one meaning the cancer was only in the breast tissue or in the lymph nodes close to the breast and she underwent chemotherapy, immunotherapy, and a double mastectomy.
